Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
Maillart E, Vidal JS, Brassat D, Stankoff B, Fromont A, de Sèze J, Taithe F, Clavelou P, Bourre B, Delvaux V, Rico A, Labauge P, Tourbah A, Lebrun C, Pelletier J, Moreau T, Louapre C, Lubetzki C, Papeix C.
Maillart E, et al. Among authors: clavelou p.
Neurol Neuroimmunol Neuroinflamm. 2017 Apr 14;4(3):e346. doi: 10.1212/NXI.0000000000000346. eCollection 2017 May.
Neurol Neuroimmunol Neuroinflamm. 2017.
PMID: 28616447
Free PMC article.